000 01719 a2200481 4500
005 20250515123354.0
264 0 _c20080819
008 200808s 0 0 eng d
022 _a1460-2180
024 7 _a10.1093/carcin/bgn118
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchwab, Markus
245 0 0 _aPPARgamma is involved in mesalazine-mediated induction of apoptosis and inhibition of cell growth in colon cancer cells.
_h[electronic resource]
260 _bCarcinogenesis
_cJul 2008
300 _a1407-14 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCaco-2 Cells
650 0 4 _aCaspase 3
_xbiosynthesis
650 0 4 _aCaspase 8
_xbiosynthesis
650 0 4 _aCell Cycle
_xdrug effects
650 0 4 _aCell Growth Processes
_xdrug effects
650 0 4 _aColonic Neoplasms
_xdrug therapy
650 0 4 _aDown-Regulation
_xdrug effects
650 0 4 _aHCT116 Cells
650 0 4 _aHT29 Cells
650 0 4 _aHumans
650 0 4 _aInhibitor of Apoptosis Proteins
_xbiosynthesis
650 0 4 _aMesalamine
_xpharmacology
650 0 4 _aPPAR gamma
_xbiosynthesis
650 0 4 _aPTEN Phosphohydrolase
_xbiosynthesis
650 0 4 _aProto-Oncogene Proteins c-myc
_xbiosynthesis
650 0 4 _aSignal Transduction
650 0 4 _aUp-Regulation
_xdrug effects
700 1 _aReynders, Veerle
700 1 _aLoitsch, Stefan
700 1 _aShastri, Yogesh M
700 1 _aSteinhilber, Dieter
700 1 _aSchröder, Oliver
700 1 _aStein, Jürgen
773 0 _tCarcinogenesis
_gvol. 29
_gno. 7
_gp. 1407-14
856 4 0 _uhttps://doi.org/10.1093/carcin/bgn118
_zAvailable from publisher's website
999 _c18030198
_d18030198